Lyell Immunopharma, Inc.LYELNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-533986.11%
↓ 253% vs avg
Percentile
P0
Near historical low
Streak
3 yr
Consecutive declineContracting
Average
-151078.81%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -533986.11% | -62.3% |
| 2024 | -328922.95% | -88.6% |
| 2023 | -174429.23% | -87283.8% |
| 2022 | -199.61% | +89.4% |
| 2021 | -1888.75% | +32.0% |
| 2020 | -2777.55% | +81.9% |
| 2019 | -15347.49% | - |